SCHEMBL14088005

SCHEMBL14088005

O=c1oc2c3c4c(cc2c(C(F)(F)F)c1-c1ccc2[nH]ccc2c1)CCCN4CCC3

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.51
▸ KMT2A Q03164 7/20 0.51
▸ ALDH1A1 P00352 7/20 0.51
▸ RECQL P46063 3/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ POLB P06746 2/20 0.51
▸ MCOLN3 Q8TDD5 1/20 0.51
▸ USP2 O75604 6/20 0.49
▸ TDP1 Q9NUW8 3/20 0.49
▸ HTT P42858 2/20 0.49
▸ KEAP1 Q14145 1/20 0.49
▸ NFE2L2 Q16236 1/20 0.49
▸ GPR35 Q9HC97 1/20 0.49
▸ MAPT P10636 5/20 0.43
▸ LMNA P02545 5/20 0.43
▸ GAA P10253 5/20 0.43
▸ KDM4E B2RXH2 4/20 0.43
▸ CASP1 P29466 4/20 0.43
▸ CASP7 P55210 4/20 0.43
▸ HPGD P15428 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14088018 0.87 MEN1 (0.45) MEN1KMT2AALDH1A1RECQLSMN1; SMN2
SCHEMBL14088001 0.79 USP2 (0.58) MEN1KMT2AALDH1A1RECQLSMN1; SMN2
SCHEMBL14408383 0.78 MEN1 (0.53) MEN1KMT2AALDH1A1RECQLSMN1; SMN2
SCHEMBL16316690 0.75 KMT2A (0.63) MEN1KMT2AALDH1A1RECQLSMN1; SMN2
SCHEMBL12153732 0.68 ALDH1A1 (0.67) MEN1KMT2AALDH1A1RECQLSMN1; SMN2
SCHEMBL12879922 0.67 ALDH1A1 (0.66) MEN1KMT2AALDH1A1RECQLSMN1; SMN2
SCHEMBL31267435 0.67 MEN1 (1.00) MEN1KMT2AALDH1A1RECQLSMN1; SMN2
SCHEMBL194764 0.67 MEN1 (1.00) MEN1KMT2AALDH1A1RECQLSMN1; SMN2
SCHEMBL17914323 0.66 ALDH1A1 (0.62) MEN1KMT2AALDH1A1RECQLSMN1; SMN2
SCHEMBL17716546 0.66 ALDH1A1 (0.48) MEN1KMT2AALDH1A1RECQLSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) MAOA, MAOB, COMT MEN1 1950/4885KMT2A 1156/4885ALDH1A1 181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback